Abstract:Background Recent research linked changes in the gut microbiota and serum metabolite concentrations to intracerebral hemorrhage (ICH). However, the potential causal relationship remained unclear. Therefore, the current study aims to estimate the effects of genetically predicted causality between gut microbiota, serum metabolites, and ICH. Methods Summary data from genome-wide association studies (GWAS) of gut microbiota, serum metabolites, and ICH were obtained separately. Gut microbiota GWAS ( N = 18,340) were acquired from the MiBioGen study, serum metabolites GWAS ( N = 7,824) from the TwinsUK and KORA studies, and GWAS summary-level data for ICH from the FinnGen R9 (ICH, 3,749 cases; 339,914 controls). A two-sample Mendelian randomization (MR) study was conducted to explore the causal effects between gut microbiota, serum metabolites, and ICH. The random-effects inverse variance-weighted (IVW) MR analyses were performed as the primary results, together with a series of sensitivity analyses to assess the robustness of the results. Besides, a reverse MR was conducted to evaluate the possibility of reverse causation. To validate the relevant findings, we further selected data from the UK Biobank for analysis. Results MR analysis results revealed a nominal association ( p < 0.05) between 17 gut microbial taxa, 31 serum metabolites, and ICH. Among gut microbiota, the higher level of genus Eubacterium xylanophilum (odds ratio (OR): 1.327, 95% confidence interval (CI):1.154–1.526; Bonferroni-corrected p = 7.28 × 10 −5 ) retained a strong causal relationship with a higher risk of ICH after the Bonferroni corrected test. Concurrently, the genus Senegalimassilia (OR: 0.843, 95% CI: 0.778–0.915; Bonferroni-corrected p = 4.10 × 10 −5 ) was associated with lower ICH risk. Moreover, after Bonferroni correction, only two serum metabolites remained out of the initial 31 serum metabolites. One of the serum metabolites, Isovalerate (OR: 7.130, 95% CI: 2.648–19.199; Bonferroni-corrected p = 1.01 × 10 −4 ) showed a very strong causal relationship with a higher risk of ICH, whereas the other metabolite was unidentified and excluded from further analysis. Various sensitivity analyses yielded similar results, with no heterogeneity or directional pleiotropy observed. Conclusion This two-sample MR study revealed the significant influence of gut microbiota and serum metabolites on the risk of ICH. The specific bacterial taxa and metabolites engaged in ICH development were identified. Further research is required in the future to delve deeper into the mechanisms behind these findings.

Dissecting causal relationships between gut microbiome, immune cells, and brain injury: A Mendelian randomization study

An Integrated Analysis of Gut Microbiota and the Brain Transcriptome Reveals Host-Gut Microbiota Interactions Following Traumatic Brain Injury.

Causality Between Gut Microbiota and Inflammatory Bowel Disease: A Bidirectional Mendelian Randomization Study

Genetically predicted causality between gut microbiota, blood metabolites, and intracerebral hemorrhage: a bidirectional Mendelian randomization study

Gut microbiota linked to hydrocephalus through inflammatory factors: a Mendelian randomization study

The causal effects between gut microbiota and hemorrhagic stroke: a bidirectional two-sample Mendelian randomization study

Genetically supported causality between gut microbiota, immune cells, and ischemic stroke: a two-sample Mendelian randomization study

Causal relationship between gut microbiota and intracranial hemorrhage: A two-sample Mendelian randomization study

Effects of immune cells in mediating the relationship between gut microbiota and myelodysplastic syndrome: a bidirectional two-sample, two-step Mendelian randomization study

Exploring the Causal Role of Gut Microbiota and Inflammatory Proteins in Neuromyelitis Optica Spectrum Disorder: a Mendelian Randomization Study with Mediation Analysis

Gut microbiota and autoimmune neurologic disorders: a two-sample bidirectional Mendelian randomization study

Dissecting Causal Links Between Gut Microbiota, Inflammatory Cytokines, and DLBCL: A Mendelian Randomization Study

A causal relationship between gut microbiota and subcortical brain structures contributes to the microbiota–gut–brain axis: a Mendelian randomization study

Causality between gut microbiota, immune cells, and breast cancer: Mendelian randomization analysis

Discussion on the relationship between gut microbiota and glioma through Mendelian randomization test based on the brain gut axis

Causal associations between gut microbiota, gut microbiota-derived metabolites, and cerebrovascular diseases: a multivariable Mendelian randomization study

Causal effects of gut microbiota on multiple sclerosis: A two‐sample Mendelian randomization study

Association between gut microbiome and intracerebral hemorrhage based on genome-wide association study data

Causal relationship between the gut microbiota, immune cells, and coronary heart disease: a mediated Mendelian randomization analysis

Dissecting Causal Relationships Between Gut Microbiota, Blood Metabolites, and Stroke: A Mendelian Randomization Study

Causal relationship between gut microflora and dementia: a Mendelian randomization study